GB0225876D0 - Use - Google Patents

Use

Info

Publication number
GB0225876D0
GB0225876D0 GB0225876A GB0225876A GB0225876D0 GB 0225876 D0 GB0225876 D0 GB 0225876D0 GB 0225876 A GB0225876 A GB 0225876A GB 0225876 A GB0225876 A GB 0225876A GB 0225876 D0 GB0225876 D0 GB 0225876D0
Authority
GB
United Kingdom
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0225876A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cyclacel Ltd
Original Assignee
Cyclacel Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cyclacel Ltd filed Critical Cyclacel Ltd
Priority to GB0225876A priority Critical patent/GB0225876D0/en
Publication of GB0225876D0 publication Critical patent/GB0225876D0/en
Priority to PCT/GB2003/001282 priority patent/WO2003082337A1/en
Priority to CNA038120852A priority patent/CN1655821A/en
Priority to JP2003579873A priority patent/JP2005527560A/en
Priority to MXPA04009396A priority patent/MXPA04009396A/en
Priority to EP03712412A priority patent/EP1487495A1/en
Priority to AU2003217024A priority patent/AU2003217024A1/en
Priority to BR0308756-5A priority patent/BR0308756A/en
Priority to US10/952,575 priority patent/US20050222054A1/en
Ceased legal-status Critical Current

Links

GB0225876A 2002-03-27 2002-11-06 Use Ceased GB0225876D0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
GB0225876A GB0225876D0 (en) 2002-11-06 2002-11-06 Use
PCT/GB2003/001282 WO2003082337A1 (en) 2002-03-27 2003-03-25 Combination comprising a cdk inhibitor and doxorubicin
CNA038120852A CN1655821A (en) 2002-03-27 2003-03-25 Combination comprising a CDK inhibitor and doxorubicin
JP2003579873A JP2005527560A (en) 2002-03-27 2003-03-25 A combination comprising a CDK inhibitor and doxorubicin
MXPA04009396A MXPA04009396A (en) 2002-03-27 2003-03-25 Combination comprising a cdk inhibitor and doxorubicin.
EP03712412A EP1487495A1 (en) 2002-03-27 2003-03-25 Combination comprising a cdk inhibitor and doxorubicin
AU2003217024A AU2003217024A1 (en) 2002-03-27 2003-03-25 Combination comprising a cdk inhibitor and doxorubicin
BR0308756-5A BR0308756A (en) 2002-03-27 2003-03-25 Combination comprising a cdk and doxorubicin inhibitor
US10/952,575 US20050222054A1 (en) 2002-03-27 2004-09-27 Combination comprising a CDK inhibitor and doxorubicin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0225876A GB0225876D0 (en) 2002-11-06 2002-11-06 Use

Publications (1)

Publication Number Publication Date
GB0225876D0 true GB0225876D0 (en) 2002-12-11

Family

ID=9947313

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0225876A Ceased GB0225876D0 (en) 2002-03-27 2002-11-06 Use

Country Status (1)

Country Link
GB (1) GB0225876D0 (en)

Similar Documents

Publication Publication Date Title
PL372902A1 (en) New use
GB0206048D0 (en) Use
GB0227666D0 (en) Use
AU2003249738A8 (en) Ostoscope
AU2003297193A8 (en) Meta-web
AU2003252028A8 (en) Heterodiamondoids
AU2003279495A8 (en) Alert-modeling
GB0217056D0 (en) Use
GB0213878D0 (en) Use
AU2002367810A8 (en) Bis-transition-metal-chelate-probes
AU2003264900A8 (en) Cast-cutter
GB0206838D0 (en) Use
AU2003262681A8 (en) Hemo-aide
GB0230343D0 (en) Use
GB0204720D0 (en) Novel use
AU2002341221A8 (en) Honey-brandy
AU2003253735A8 (en) Vacuolins
GB0210682D0 (en) Novel use
GB0229442D0 (en) Use
GB0222408D0 (en) Use
GB0220135D0 (en) Use
GB0214802D0 (en) Use
GB0207228D0 (en) Use
GB0206203D0 (en) Use
GB0225876D0 (en) Use

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)